Precision Imaging to Evaluate Kaposi Sarcoma

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorWashington University School of Medicine

About this trial

AIMS 2 \& 3:

In this study the investigators seek to formally compare reproducibility and accuracy of KS lesion size measurements between SkinScan3D and the current standard of care manual measurement method. The investigators will then test the SS3D device on 100 patients in a variety of real-world practice locations to determine whether the device will be usable, acceptable, appropriate, and feasible in routine care settings.

Eligibility criteria

Qualifiers

Adults age ≥18 years old

Histopathology-confirmed Kaposi Sarcoma

At least 3 skin lesions

Capable of informed consent

Disqualifiers

Patients not initiating Kaposi Sarcoma treatment

Very ill patients requiring hospitalization

Adults age ≥18 years old

Histopathology-confirmed Kaposi Sarcoma

Trial design

Treatments tested in this trial

  • SkinScan3D

Treatment groups

300 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Washington University School of Medicine

Lead sponsor

National Cancer Institute (NCI)

Collaborator

Pensievision

Collaborator

Kenya Medical Research Institute

Collaborator

Makerere University

Collaborator